Resurrect Bio · Series A

Reactivating dormant disease resistance genes already in crops

Amount

$10.3M

Round

Series A

Valuation

—

Announced

May 2026

Investors

Lead investor

Corteva Catalyst

Participating investors

UKI2S AgFunder SynBioVen Calculus Capital Pymwymic